Anne Boulay
Roche (Switzerland)(CH)Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Inserm(FR)Collège de France(FR)Université Paris Sciences et Lettres(FR)Centre Interdisciplinaire de Recherche en Biologie(FR)
Publications by Year
Research Areas
Barrier Structure and Function Studies, Estrogen and related hormone effects, Melanoma and MAPK Pathways, Neuroinflammation and Neurodegeneration Mechanisms, Advanced Breast Cancer Therapies
Most-Cited Works
- → The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation(2005)490 cited
- → Trial of Prasinezumab in Early-Stage Parkinson’s Disease(2022)368 cited
- → Dual Inhibition of mTOR and Estrogen Receptor SignalingIn vitroInduces Cell Death in Models of Breast Cancer(2005)335 cited
- → Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells(2004)319 cited
- → mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor(2009)251 cited
- → Deletion of Astroglial Connexins Weakens the Blood–Brain Barrier(2012)214 cited